Report cover image

Human Capital Management Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Services); By Deployment Model (On-premises, Cloud); By Organization Size; By Vertical; By Region; Segment Forecast, 2022 - 2030

Published Sep 01, 2025
Length 114 Pages
SKU # PLRS20470310

Description

The global human capital management market size is expected to reach USD 61.73 billion by 2034, according to a new study by Polaris Market Research. The report “Human Capital Management Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Services); By deployment model (On-premises, Cloud); By organization size; By vertical; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising cloud adoption among enterprises to better manage office employees and concerned work create many HCM vendor opportunities. The cloud-based deployment model provides advantages such as profitability, ease and speed of deployment, and more rapid application administration and operations. On-premises deployment is more expensive and risky than SaaS-based deployment, which provides flexibility and stability to most organizations. Furthermore, it reduces expenditure and maximizes asset return.

Further, HCM and (CRM) migrated to the cloud. These cloud-based human capital administration solutions enable businesses to create avenues for effective employee engagement tools. Recruiting, mentoring, and learning tools help use plugins and application programming interfaces (APIs).

However, enterprises are concerned about security, so most HCM software is hosted in the cloud and managed by a third party. Cloud-based software frequently includes robust security features. This eliminates the risk of hacking or security breaches. Nonetheless, many business owners are often reluctant to move HR files and systems to the cloud, typically containing sensitive employee data. As a result, enterprises are not prepared to move their employee records, payroll, and administrative information to the cloud.

Based on the component, the service segment accounted for the leading share in the industry. Increasing software implementation to control the entire employee lifecycle and the expanding need to comply with regulatory requirements are critical factors driving the software segment to have the highest industry share during the forecast period.

Market players such as Bamboo HR, Automatic Data Processing, Benefitfocus, Bitrix, Cornerstone, Gusto, Infor, Workforce Software, Epicor Software, Kronos Incorporated, Meta4, Namely, Oracle Corporation, Paychex, Paylocity Corporation, Paycom Software, PeopleStrategy, Ramco Systems, Sage Group, SAP SE, Workday, Inc, Ultimate Software, Zenefits, and Zoho are key players operating in the global market. In June 2021, Ceridian and PwC UK formed a partnership in which PwC UK would provide counseling and implementation services for Ceridian's award-winning HCM platform, Dayforce, to current and new customers in the UK and Ireland.

Polaris market research has segmented the human capital management market report based on component, deployment mode, organization size, vertical, and region:

Human Capital Management, Component Outlook (Revenue - USD Billion, 2020 - 2034)

Software

Core HR

Applicant Tracking System

HR Analytics

Workforce Management

Services

Integration and Implementation

Training and Education

Support and Maintenance

Consulting

Human Capital Management, Deployment Mode Outlook (Revenue - USD Billion, 2020 - 2034)

On-premises

Cloud

Human Capital Management, Organization Size Outlook (Revenue - USD Billion, 2020 - 2034)

Small and Medium-sized Enterprises (SMEs)

Large Enterprises

Human Capital Management, Vertical Outlook (Revenue - USD Billion, 2020 - 2034)

Banking, Financial Services, and Insurance (BFSI)

Government

Manufacturing

Telecom and IT

Consumer Goods and Retail

Healthcare and Life Sciences

Energy and Utilities

Transportation and Logistics

Others

Human Capital Management, Regional Outlook (Revenue - USD Billion, 2018 – 2030)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Spain

Russia

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

114 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Antibiotics Market Insights
4.1. Antibiotics Market – Market Snapshot
4.2. Antibiotics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Growing Geriatric Population
4.2.1.2. Advancements in Research and Development
4.2.2. Restraints and Challenges
4.2.2.1. Economic and Financial Challenge due to Low Profitability
4.2.3. Public opinion and privacy legal precedents
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Antibiotics Market Trends
4.6. Value Chain Analysis
5. Antibiotics Market, By Drug Class
5.1. Key Findings
5.2. Introduction
5.2.1. Antibiotics Market, By Drug Class, 2020–2034 (USD Billion)
5.3. Cephalosporin
5.3.1. Antibiotics Market, by Cephalosporin,2020–2034 (USD Billion)
5.4. Penicillin
5.4.1. Antibiotics Market, by Penicillin,2020–2034 (USD Billion)
5.5. Fluoroquinolone
5.5.1. Antibiotics Market, by Fluoroquinolone,2020–2034 (USD Billion)
5.6. Macrolides
5.6.1. Antibiotics Market, by Macrolides,2020–2034 (USD Billion)
5.7. Carbapenems
5.7.1. Antibiotics Market, by Carbapenems,2020–2034 (USD Billion)
5.8. Aminoglycosides
5.8.1. Antibiotics Market, by Aminoglycosides,2020–2034 (USD Billion)
5.9. Sulfonamides
5.9.1. Antibiotics Market, by Sulfonamides,2020–2034 (USD Billion)
5.10. 7-ACA
5.10.1. Antibiotics Market, by 7-ACA,2020–2034 (USD Billion)
5.11. Others
5.11.1. Antibiotics Market, by Others,2020–2034 (USD Billion)
6. Antibiotics Market, By Type
6.1. Key Findings
6.2. Introduction
6.2.1. Antibiotics Market, By Type, 2020–2034 (USD Billion)
6.3. Branded Antibiotics
6.3.1. Antibiotics Market, by Branded Antibiotics,2020–2034 (USD Billion)
6.4. Generic Antibiotics
6.4.1. Antibiotics Market, by Generic Antibiotics,2020–2034 (USD Billion)
7. Antibiotics Market, By Action Mechanism
7.1. Key Findings
7.2. Introduction
7.2.1. Antibiotics Market, By Action Mechanism, 2020–2034 (USD Billion)
7.3. Cell Wall Synthesis Inhibitors
7.3.1. Antibiotics Market, by Cell Wall Synthesis Inhibitors,2020–2034 (USD Billion)
7.4. Protein Synthesis Inhibitors
7.4.1. Antibiotics Market, by Protein Synthesis Inhibitors,2020–2034 (USD Billion)
7.5. DNA Synthesis Inhibitors
7.5.1. Antibiotics Market, by DNA Synthesis Inhibitors,2020–2034 (USD Billion)
7.6. RNA Synthesis Inhibitors
7.6.1. Antibiotics Market, by RNA Synthesis Inhibitors,2020–2034 (USD Billion)
7.7. Mycolic Acid Inhibitors
7.7.1. Antibiotics Market, by Mycolic Acid Inhibitors,2020–2034 (USD Billion)
8. Antibiotics Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Antibiotics Market Assessment, By Geography, by Region, 2020-2034 (USD Billion)
8.3. Antibiotics Market – North America
8.3.1. North America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.3.2. North America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.3.3. North America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.3.4. Antibiotics Market – US
8.3.4.1. US: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.3.4.2. US: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.3.4.3. US: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.3.5. Antibiotics Market – Canada
8.3.5.1. Canada: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.3.5.2. Canada: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.3.5.3. Canada: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4. Antibiotics Market – Europe
8.4.1. Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.2. Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.3. Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.4. Antibiotics Market – UK
8.4.4.1. UK: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.4.2. UK: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.4.3. UK: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.5. Antibiotics Market – France
8.4.5.1. France: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.5.2. France: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.5.3. France: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.6. Antibiotics Market – Germany
8.4.6.1. Germany: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.6.2. Germany: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.6.3. Germany: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.7. Antibiotics Market – Italy
8.4.7.1. Italy: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.7.2. Italy: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.7.3. Italy: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.8. Antibiotics Market – Spain
8.4.8.1. Spain: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.8.2. Spain: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.8.3. Spain: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.9. Antibiotics Market – Netherlands
8.4.9.1. Netherlands: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.9.2. Netherlands: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.9.3. Netherlands: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.10. Antibiotics Market – Russia
8.4.10.1. Russia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.10.2. Russia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.10.3. Russia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4.11. Antibiotics Market – Rest of Europe
8.4.11.1. Rest of Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.4.11.2. Rest of Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.4.11.3. Rest of Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5. Antibiotics Market – Asia Pacific
8.5.1. Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.2. Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.3. Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.4. Antibiotics Market – China
8.5.4.1. China: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.4.2. China: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.4.3. China: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.5. Antibiotics Market – India
8.5.5.1. India: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.5.2. India: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.5.3. India: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.6. Antibiotics Market – Malaysia
8.5.6.1. Malaysia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.6.2. Malaysia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.6.3. Malaysia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.7. Antibiotics Market – Japan
8.5.7.1. Japan: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.7.2. Japan: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.7.3. Japan: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.8. Antibiotics Market – Indonesia
8.5.8.1. Indonesia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.8.2. Indonesia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.8.3. Indonesia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.9. Antibiotics Market – South Korea
8.5.9.1. South Korea: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.9.2. South Korea: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.9.3. South Korea: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.10. Antibiotics Market – Australia
8.5.10.1. Australia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.10.2. Australia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.10.3. Australia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5.11. Antibiotics Market – Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.5.11.2. Rest of Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.5.11.3. Rest of Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.6. Antibiotics Market – Middle East & Africa
8.6.1. Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.6.2. Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.6.3. Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.6.4. Antibiotics Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.6.4.2. Saudi Arabia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.6.4.3. Saudi Arabia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.6.5. Antibiotics Market – UAE
8.6.5.1. UAE: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.6.5.2. UAE: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.6.5.3. UAE: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.6.6. Antibiotics Market – Israel
8.6.6.1. Israel: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.6.6.2. Israel: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.6.6.3. Israel: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.6.7. Antibiotics Market – South Africa
8.6.7.1. South Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.6.7.2. South Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.6.7.3. South Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.6.8. Antibiotics Market – Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.6.8.2. Rest of Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.6.8.3. Rest of Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.7. Antibiotics Market – Latin America
8.7.1. Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.7.2. Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.7.3. Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.7.4. Antibiotics Market – Mexico
8.7.4.1. Mexico: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.7.4.2. Mexico: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.7.4.3. Mexico: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.7.5. Antibiotics Market – Brazil
8.7.5.1. Brazil: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.7.5.2. Brazil: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.7.5.3. Brazil: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.7.6. Antibiotics Market – Argentina
8.7.6.1. Argentina: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.7.6.2. Argentina: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.7.6.3. Argentina: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.7.7. Antibiotics Market – Rest of Latin America
8.7.7.1. Rest of Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
8.7.7.2. Rest of Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
8.7.7.3. Rest of Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Astellas Pharma Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. AstraZeneca
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Cipla
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Fresenius Kabi AG
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. GSK plc
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Hetero Healthcare Limited
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Lupin Pharmaceuticals, Inc
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Merck & Co., Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Pfizer Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Teva Pharmaceutical Industries Ltd.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.